Formulation development and in vitro evaluation of nanosuspensions loaded with Atorvastatin calcium

Asian Journal of Pharmaceutics

Volumn 4, Issue 1, 2010, Pages 28-33

  Arunkumar, N ^a   Deecaraman, M ^b   Rani, C ^c   Mohanraj, K P ^d   Venkateskumar, K ^a  

^a KMCH COLLEGE OF PHARMACY   (India)

^b DR M G R EDUCATIONAL AND RESEARCH INSTITUTE   (India)

^c SB College of Pharmacy   (India)

^d JADAVPUR UNIVERSITY   (India)

Author keywords

Atorvastatin; crystalline state; dissolution; high pressure homogenization; nanosuspensions

Indexed keywords

ATORVASTATIN;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; NANOSUSPENSION; PARTICLE SIZE; PHASE TRANSITION; SUSPENSION; TECHNIQUE; THERMOGRAVIMETRY; X RAY POWDER DIFFRACTION;

EID: 77953868719     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.63982     Document Type: Article

References (20)

1. The Bio pharmaceutics Classification System (BCS) Guidance, Office of Pharmaceutical Science. Available from: http://www.fda.gov/cder/OPS/BCS- guidance.htm. [last accessed on 2008 Jan 12].
2. Clewlow PJ. Survival of the smartest: Scrip's target world drug delivery news. Informa Healthcare, UK 2004;35:316-323
3. Seedher N, Kaur J. Solubilization of nimesulide: Use of co-solvents. Indian J Pharm Sci 2003;65:58-61.
4. Mersiko-Liversidge E, MGurk SL, Liversidge GG. Insulin nanoparticles: A novel formulation approach for poorly water soluble Zn-Insulin. Pharm Res 2004;21:1545-1553
5. Benjamin C, Lu Y, Zang D, Sheng W. Solubility enhancement in supercritical fluids. Pure Appl Chem 1990;62:2277-2285
6. Paradkar A, Ambike A, Jadhav B, Mahadik K. Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int J Pharm 2004;271:281-286
7. Anzai K, Mizoguchi J, Yanagi T, Hirayama F, Arima H, Uekama K. Improvement of dissolution properties of a new Helicobacter pylori eradicating agent (TG44) by inclusion complexation with beta-cyclodextrin. Chem Pharm Bull 2007;55:1466-1470
8. Sucker H. Hydrosole, eine Alternative für die parenterale Anwendung von schwer wasserlöslichen Wirkstoffen. In: Muller RH, Hildebrand GE, editors. Pharmazeutische Technologie; Modern Arzneiformen. 2nd ed. Stuttgart: WVG; 1998.
9. Lennernas H. Clinical pharmacokinetics of atorvastatin. Clin Pharmacokinet 2003;42:1141-1160
10. Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, Bernini F. New insights into the pharmacodynamic and pharmacokinetic propserties of statins. Pharmacol Ther 1999;84:413-428
11. Hecq J, Deleers M, Fanara D, Vrandex H, Amighi K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm 2005;299:167-177
12. Gohel MC, Patel LD. Processing of Nimesulide-PEG 400-PEG-PVP solid dispersions: Preparation, characterization and in vitro dissolution. Drug Dev Ind Pharm 2003;29:299-310.
13. Sunil KB, Michael AR, Soumyajit M, Rao Y. Formulation and evaluation of rapidly disintegrating Fenoverine tablets: Effect of superdisintegrant. Drug Dev Ind Pharm 2007;33:1225-1232
14. Mehdi A, Maryam K, Monireh A. The study of drug permeation through natural membrane. Int J Pharm 2006;327:6-11.
15. Giovanna C, Francesca M, Marzia C, Sandra F, Paola M. Development and evaluation of an in vitro method for prediction of human drug absorption 1: Assessment of artificial membrane composition. Eur J Pharm Sci 2006;27:346-353
16. Kim MS, Jin SJ, Kim JS, Park HJ, Song HS, Neubertb RH, et al. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm 2008;69:454-465
17. Kocbek P, Baumgartner S, Kristi J. Preparation and evaluation of nanosuspensions for enhancing dissolution of poorly soluble drugs. Int J Pharm 2006;312:179-186
18. Yuichi T, Atsutoshi I, Hiiroko S, Toshio O, Keiji Y. Characterization and quantitation of Clarithromycin polymorphs by powder X-Ray diffractometry and solid state NMR spectroscopy. Chem Pharm Bull 2002;50:1128-1130
19. Jacobs C, Muller RH. Production and characterization of budenoside nanosuspensions for pulmonary administration. Pharm Res 2002;19:189-194
20. Kim JS, Kim MS, Park HJ, Jin SJ, Sibeum L, Hwang SJ. Physiochemical properties and oral bioavailability of amorphous atrovastatin hemi-calcium using spray-drying and SAS process. Int J Pharm 2008;359:211-219